-
-
Call more information
660-596-2224 -
Published in Br J Anaesth. 2015 Apr;114(4):634-9 Authors: Zou ZY et al BACKGROUND: To investigate the effects of different target plasma remifentanil concentrations on the minimum alveolar concentration of sevoflurane (MAC) for blocking adrenergic response (BAR) during laparoscopic gynaecological surgery with carbon dioxide insufflation. METHODS: Seventy-five gynaecological patients with ASA I-II undergoing laparoscopic surgery were […]
Read MorePublished in J Obstet Gynaecol. 2014 Dec 29:1-4 Authors: Genc M et al In this study we aimed to explore the effects of epidural analgesia achieved by a combination of low-dose bupivacaine and fentanyl infused through an epidural catheter on mother, foetus and labour process in nulliparous at-term pregnant women during vaginal delivery. This study […]
Read MorePatients with fibromyalgia can safely be treated with the anticonvulsant drug pregabalin (Lyrica, Pfizer Inc) for their pain while at the same time being treated for depression, a new study shows. Results of a double-blind study showed that pregabalin significantly improved mean pain scores compared with placebo in patients with fibromyalgia taking a selective serotonin […]
Read MoreConcerns over addiction and drug abuse are causing some primary care physicians (PCPs) to prescribe fewer opioids for chronic pain, according to a recent national survey on prescription drug abuse. The clinical use of prescription opioids for treating chronic pain nearly doubled from 2000 to 2010, along with an increase in opioid abuse, addiction, injury […]
Read MoreThe FDA has approved Hospira, Inc.’s Dyloject (diclofenac sodium) Injection. The proprietary nonsteroidal anti-inflammatory drug (NSAID) is indicated for the treatment of adults with mild to moderate pain and for the management of moderate to severe pain alone or in combination with opioid analgesics. “While not a replacement for opioids, Dyloject is [an] injectable therapy […]
Read More